Clinical Trial Update: Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation [Phase 3]

View source ↗

Summary

Phase 3 trial update on prevention of graft-versus-host disease in patients with advanced leukemia or lymphoma undergoing peripheral stem cell transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Leukemia
• Lymphoma

Snippet

Sponsor: Baxalta now part of Shire | Conditions: Leukemia, Lymphoma | Phase 3 | Status: TERMINATED